RetroSense Therapeutics’ Investors See Exit, Bright Future Ahead
ANN ARBOR - An investment made by several groups of early-stage Michigan investors could pay off in a big way following the recent news that Allergan acquired Ann Arbor-based RetroSense Therapeutics LLC, a Michigan angel-backed gene therapy company, for $60 million plus additional funding if the company reaches future milestones. Terry Cross, MVCA member, and









